Search results for "psychosis."

showing 10 items of 317 documents

The EUropean Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI)

2020

Funder: FP7 Ideas: European Research Council; doi: http://dx.doi.org/10.13039/100011199; Grant(s): HEALTH-F2-2010-241909

MaleHealth (social science)EpidemiologyEthnic groupEthnic GroupGene-environment interactionsEnvironment–environment interactions0302 clinical medicineEpidemiologyEthnicity10. No inequalityFirst episodeRISKbiologyIncidence (epidemiology)IncidenceCANNABISMiddle AgedCase-controlFirst-episode psychosis3. Good healthEuropePsychiatry and Mental healthCase–control Environment–environment interactions EU-GEI First-episode psychosis Gene–environment interactions IncidenceCase–control; EU-GEI; Environment–environment interactions; First-episode psychosis; Gene–environment interactions; IncidenceSchizophreniaCohortFemalePsychologyCase-Control StudieCase–controlBrazilHumanAdultmedicine.medical_specialtySocial PsychologyAdolescentStudy Protocols and SamplesDISORDERSEnvironment–environment interactionRepresentativeness heuristicEU-GEIGene–environment interactions03 medical and health sciencesYoung AdultPSYCHOSISAGEFirst-episode psychosiEnvironment-environment interactionsmedicineHumansGene–environment interactionSettore MED/25 - PsichiatriaMETAANALYSISbiology.organism_classificationmedicine.disease030227 psychiatryCase-Control StudiesSchizophreniaGene-Environment InteractionCannabisCHILDHOOD ADVERSITIES030217 neurology & neurosurgeryDemographySocial Psychiatry and Psychiatric Epidemiology
researchProduct

Physical activity correlates among people with psychosis: Data from 47 low- and middle-income countries

2018

Background: People with schizophrenia engage in low levels of physical activity (PA). However, few large-scale studies have investigated the factors that may influence PA participation in individuals with psychosis and data from low- and middle-income countries (LMICs) is especially scarce. Thus, we investigated PA correlates in a large sample of people with a psychosis diagnosis across 47 LMICs. Methods: Cross-sectional data from the World Health Survey, restricting to those with a self-reported lifetime diagnosis of schizophrenia/psychotic disorder, was analyzed. PA was assessed by the International Physical Activity Questionnaire (IPAQ) and participants were dichotomized into those that …

MaleHealth BehaviorPsychological intervention*PsychosisGlobal Health0302 clinical medicine*Developing countries/dk/atira/pure/subjectarea/asjc/2800/2803Developing countrie*ExerciseMobilityPsychiatry/dk/atira/pure/subjectarea/asjc/2700/2738*Physical activityPsychiatry and Mental healthSchizophreniaPsychiatry and Mental HealthMarital statusAnxietyFemaleBiological psychiatrymedicine.symptomPsychologyPsychosismedicine.medical_specialtyDeveloping countries; Exercise; Mobility; Physical activity; Psychiatry; Psychosis; Schizophrenia; Psychiatry and Mental Health; Biological PsychiatryPsychosiDeveloping countries03 medical and health sciencesmedicineHumansPsychiatryExerciseBiological PsychiatryPhysical activity*SchizophreniaOdds ratiomedicine.diseasePsychosisHealth Surveys030227 psychiatryCross-Sectional StudiesPsychotic DisordersSocioeconomic FactorsSchizophrenia*Psychiatry*Mobility030217 neurology & neurosurgeryDemographyDiagnosis of schizophrenia
researchProduct

First-episode psychosis and migration in Italy (PEP-Ita migration): A study in the Italian mental health services

2014

Abstract Background It has been frequently reported a higher incidence of psychotic disorders in immigrants than in native populations. There is, however, a lack of knowledge about risk factors which may explain this phenomenon. A better understanding of the causes of psychosis among first-generation migrants is highly needed, particularly in Italy, a country with a recent massive migration. Methods/Design The “Italian study on first-episode psychosis and migration (PEP-Ita)” is a prospective observational study over a two-year period (1 January 2012–31 December 2013) which will be carried out in 11 Italian mental health centres. All participating centres will collect data about all new cas…

MaleImmigrationEthnic groupStudy ProtocolEthnicitySettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.Prospective Studies10. No inequalitymedia_commonFirst-episode psychosis; Italy; Migrants; Protective factors; Risk factorsTransients and Migrantseducation.field_of_studyProtective factorIncidenceMiddle AgedFirst-episode psychosisPsychiatry and Mental healthMental HealthItaly8. Economic growthFemalePsychopathologyAdultMental Health Servicesmedicine.medical_specialtyPsychosisAdolescentmedia_common.quotation_subjectPopulationEmigrants and ImmigrantsMigrants First-episode psychosis Italy Risk factors Protective factorsMigrantsYoung AdultFirst-episode psychosiIntervention (counseling)medicineHumansPsychiatryeducationSettore MED/25 - Psichiatriabusiness.industryMigrantmedicine.diseaseMental healthProtective factorsRisk factorsPsychotic DisordersObservational studybusiness
researchProduct

Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countries.

2016

BACKGROUND: In people with psychosis, physical comorbidities, including cardiovascular and metabolic diseases, are highly prevalent and leading contributors to the premature mortality encountered. However, little is known about physical health multimorbidity in this population or in people with subclinical psychosis and in low- and middle-income countries (LMICs). This study explores physical health multimorbidity patterns among people with psychosis or subclinical psychosis. METHODS: Overall, data from 242,952 individuals from 48 LMICs, recruited via the World Health Survey, were included in this cross-sectional study. Participants were subdivided into those (1) with a lifetime diagnosis o…

MaleInternationalityCross-sectional studyComorbidityMetabolism Multimorbidity Physical health Psychosis Psychotic experiencesGlobal HealthLogistic regressionnot known0302 clinical medicinePrevalencepsychosisSubclinical infectionPsychosisPhysical healthMultimorbidityPsychotic experiencesMetabolismmetabolismmultimorbidityphysical healthpsychosispsychotic experiencesMedicine(all)Principal Component Analysiseducation.field_of_studyGeneral MedicineMiddle AgedCardiovascular DiseasesFemalemedicine.symptomAdultPsychosismedicine.medical_specialtyAdolescentmultimorbidityVisual impairmentPopulationPhysical healthYoung Adult03 medical and health sciencesMetabolic DiseasesmedicineHumansPsychotic experiencesPsychiatryeducationPovertyAgedbusiness.industryPublic healthMultimorbidityPsychosismedicine.diseaseHealth SurveysComorbidity030227 psychiatryCross-Sectional StudiesMetabolismPsychotic DisordersChronic Diseasebusiness030217 neurology & neurosurgery
researchProduct

Heterogeneity in Risk Factors for Cognitive Impairment, No Dementia: Population-Based Longitudinal Study From the Kungsholmen Project

2006

OBJECTIVES: The objectives of this study were to investigate the relation of vascular, neuropsychiatric, social, and frailty-related factors with "Cognitive impairment, no dementia" (CIND) and to verify their effect independently of future progression to Alzheimer disease (AD). METHODS: Seven hundred eighteen subjects aged 75+ years who attended baseline, 3- and 6-year follow-up examinations of the Kungsholmen Project, a Swedish prospective cohort study, were studied. CIND was defined according to the performance on the Mini-Mental State Examination. Potential risk factors were collected at baseline and clustered according to four research hypotheses (frailty, vascular, neuropsychiatric, an…

MaleLongitudinal studyPsychosisPopulationAlzheimer DiseaseRisk FactorsActivities of Daily Livingmental disordersmedicineHumansDementiaeducationProspective cohort studyAgedProportional Hazards ModelsAged 80 and overSwedenPolypharmacyeducation.field_of_studyHip fractureHip FracturesMild cognitive impairment Alzheimer disease hip fracture polypharmacy psychosismedicine.diseasePsychiatry and Mental healthPsychotic DisordersDisease ProgressionPolypharmacyFemaleSettore MED/26 - NeurologiaGeriatrics and GerontologyAlzheimer's diseaseCognition DisordersPsychologyFollow-Up StudiesClinical psychologyThe American Journal of Geriatric Psychiatry
researchProduct

Jumping to conclusions, general intelligence, and psychosis liability: Findings from the multi-centre EU-GEI case-control study

2021

This study was funded by the Medical Research Council, the European Community’s Seventh Framework Program grant [agreement HEALTH-F2-2009-241909 (Project EU-GEI)], São Paulo Research Foundation (grant 2012/0417-0), the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and King’s College London, the NIHR BRC at University College London and the Wellcome Trust (grant 101272/Z/12/Z).

MaleMISCOMPREHENSIONIntelligenceDELÍRIO0302 clinical medicineCognitionSCHIZOPHRENIApsychotic-like experiencejumping to conclusionsApplied PsychologyProblem SolvingRISKeducation.field_of_studyCognitionMiddle Aged16. Peace & justiceCognitive bias3. Good healthFirst episode psychosis; IQ; jumping to conclusions; polygenic risk score; psychotic-like experiences; symptom dimensionsPsychiatry and Mental healthBIASSchizophreniaRELIABILITYFemaleOriginal Articlejumping to conclusion[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]medicine.symptomClinical psychologyAdultPsychosisFirst episode psychosisAdolescentDISORDERSPopulationREEXAMINATIONDelusionssymptom dimensions03 medical and health sciencesYoung AdultPEOPLEmedicineHumansCognitive DysfunctioneducationDELUSIONAL IDEATIONCognitive deficitpsychotic-like experiencesbusiness.industryCase-control studymedicine.diseaseFirst episode psychosi030227 psychiatryPsychotic DisordersIQCase-Control StudiesJumping to conclusionspolygenic risk scorebusiness030217 neurology & neurosurgeryPsychological medicine
researchProduct

The Maudsley Environmental Risk Score for Psychosis

2018

AbstractBackgroundRisk prediction algorithms have long been used in health research and practice (e.g. prediction of cardiovascular disease and diabetes). However, similar tools have not been developed for mental health. For example, for psychotic disorders, attempts to sum environmental risk are rare, unsystematic and dictated by available data. In light of this, we sought to develop a valid, easy to use measure of the aggregate environmental risk score (ERS) for psychotic disorders.MethodsWe reviewed the literature to identify well-replicated and validated environmental risk factors for psychosis that combine a significant effect and large-enough prevalence. Pooled estimates of relative r…

MaleMarijuana AbusePsychosisUrban PopulationPopulationEthnic groupDiseaseEnvironmentRisk AssessmentPaternal Agerisk prediction03 medical and health sciences0302 clinical medicineAdverse Childhood ExperiencesPregnancyRisk FactorsEnvironmental healthEthnicitymedicineHumanspsychosisRisk factoreducationMinority GroupsApplied Psychologyeducation.field_of_studybusiness.industryOriginal ArticlesOdds ratiomedicine.diseaseMental healthObstetric Labor Complications3. Good health030227 psychiatryschizophreniaPsychiatry and Mental healthPsychotic DisordersSchizophreniaRelative riskFemaleliabilitybusiness030217 neurology & neurosurgery
researchProduct

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.

2019

Background: Cannabis use is associated with increased risk of later psychotic disorder but whether it affects incidence of the disorder remains unclear. We aimed to identify patterns of cannabis use with the strongest effect on odds of psychotic disorder across Europe and explore whether differences in such patterns contribute to variations in the incidence rates of psychotic disorder. Methods: We included patients aged 18–64 years who presented to psychiatric services in 11 sites across Europe and Brazil with first-episode psychosis and recruited controls representative of the local populations. We applied adjusted logistic regression models to the data to estimate which patterns of canna…

MaleMarijuana Abusecannabis psychosis first episode psychosis incidenceENGLANDHIGH-POTENCY CANNABIS0302 clinical medicineSCHIZOPHRENIAOdds RatioMedicine030212 general & internal medicinepsychosisSalut mentalRISKeducation.field_of_studybiologyIncidence (epidemiology)IncidenceArticlesASSOCIATIONMiddle Aged3. Good healthEuropePsychiatry and Mental healthPUBLIC-HEALTHFemaleCase-Control StudieBrazilHumanAdultmedicine.medical_specialtyPsychosisPopulationPsychotic DisorderOdds03 medical and health sciencesYoung Adultfirst episode psychosisJournal ArticleHumanseducationSettore MED/25 - PsichiatriaBiological PsychiatryCannabisbusiness.industryLONDONPublic healthCase-control studyOdds ratiobiology.organism_classificationmedicine.diseaseTRENDS030227 psychiatryPsychotic DisordersMARIJUANACase-Control StudiesCannabisDroguesbusinessDemography
researchProduct

Niemann-Pick disease type C symptomatology: an expert-based clinical description

2013

Niemann-Pick disease type C (NP-C) is a rare, progressive, irreversible disease leading to disabling neurological manifestations and premature death. The estimated disease incidence is 1:120,000 live births, but this likely represents an underestimate, as the disease may be under-diagnosed due to its highly heterogeneous presentation. NP-C is characterised by visceral, neurological and psychiatric manifestations that are not specific to the disease and that can be found in other conditions. The aim of this review is to provide non-specialists with an expert-based, detailed description of NP-C signs and symptoms, including how they present in patients and how they can be assessed. Early dise…

MalePediatricsmedicine.medical_specialtyPsychosisAtaxiaReviewDiseaseGelastic cataplexyDysarthriaDiagnosisMiglustatHumansMedicineGenetics(clinical)Pharmacology (medical)Lysosomal lipid storage diseaseVertical supranuclear gaze palsyCognitive declineGenetics (clinical)DystoniaMedicine(all)Niemann–Pick disease type Cbusiness.industryNiemann-Pick disease type CNiemann-Pick Disease Type CGeneral Medicinemedicine.diseaseDystoniaCognitive impairmentSplenomegalyAtaxiaFemalemedicine.symptombusinessmedicine.drugOrphanet Journal of Rare Diseases
researchProduct

Identifying extended psychosis phenotypes at school: Associations with socio-emotional adjustment, academic, and neurocognitive outcomes

2020

The main goal of the present study was to explore the latent structure of extended psychosis phenotypes in a representative sample of adolescents. Moreover, associations with socio-emotional adjustment, academic achievement, and neurocognition performance across the latent profiles were compared. Participants were 1506 students, 667 males (44.3%), derived from random cluster sampling. Various tools were used to measure psychosis risk, subjective well-being, academic performance, and neurocognition. Based on three psychometric indicators of psychosis risk (schizotypal traits, psychotic-like experiences, and bipolar-like experiences), four latent classes were found: non-risk, low-risk, high r…

MalePsychometricsEpidemiologyEmotionsSocial SciencesAcademic achievementAcademic SkillsAdolescentsFamilies0302 clinical medicineSociologySurveys and QuestionnairesAcademic PerformanceMedicine and Health SciencesPsychologyChildrenMultidisciplinarySchoolsIncidence (epidemiology)QRPhenotypeMedicineFemalePsychologyClinical psychologyResearch ArticlePsychosisPsychometricsAdolescentScienceMEDLINENeurocognitive DisordersChild WelfareEmotional AdjustmentEducationSchizotypal Personality Disorder03 medical and health sciencesYoung AdultMental Health and PsychiatrymedicineHumansStudentsSocio emotionalCognitive PsychologyPsychosesBiology and Life Sciencesmedicine.diseaseMental health030227 psychiatryPsychotic DisordersAge GroupsMedical Risk FactorsPeople and PlacesCognitive SciencePopulation GroupingsSelf ReportNeurocognitive030217 neurology & neurosurgeryNeurosciencePLoS ONE
researchProduct